India Logistics Market Size to Hit US$ 432.4 Billion at 8.8% CAGR by 2028 | IMARC Group

Business Wire India - Multimedia Multimedia By Business Wire India

Table of Contents Kris Gopalakrishnan Bestowed with ISB Research Catalyst Award Rusan Pharma Unveils Its State-of-the-Art Facility for APIs in Pithampur, Madhya Pradesh Merck Foundation Marks International Day of Elimination of Violence Against Women

Kris Gopalakrishnan Bestowed with ISB Research Catalyst Award Saturday 25 November 2023 05:45 AM UTC+00 Business Wire India The Indian School of Business (ISB) bestowed Kris Gopalakrishnan, Chairman of Axilor Ventures, with the 'ISB Research Catalyst Award' for his pioneering role in the growth of the research ecosystem in India at the inaugural edition of 'ISB Insights Forum' at the Mohali campus of ISB.    Rakesh Bharti Mittal, Vice-Chairman of Bharti Enterprises and Member, ISB Executive Board and Madan Pillutla, Dean, ISB presented the award to Kris Gopalakrishnan. The ISB Research Catalyst Award has been instituted to honour philanthropists involved in advancing research in all fields in India and across the world.    Before the award was conferred, a fireside chat featuring Kris Gopalakrishnan and Rakesh Bharti Mittal was moderated by John Reed, South Asia Editor of Financial Times.    During the conversation, Kris Gopalakrishnan called on the need to use technology to improve the quality of life of Indians. He said, "The need for research and development is being increasingly felt, and forums like these are now discussing that. I am optimistic that once we decide to do something, we will do it."   Rakesh Bharti Mittal said, "I believe that if the research ecosystem can be programmed, then there can be a large amount of money which will come into it. We will get cutting-edge and efficient research, which India can deliver. Look at space. We have demonstrated that at a very frugal cost, we can send a rocket to the moon. We can go to Mars. There is no dearth of talent in India."   ISB organised the inaugural edition of ISB Insights Forum 2023 at its campus in Mohali on November 24, 2023. This was a first-of-its-kind conclave that brought together industry, policymakers, academicians, and a diverse group of people to articulate their vision of India in 2047.

Rusan Pharma Unveils Its State-of-the-Art Facility for APIs in Pithampur, Madhya Pradesh Saturday 25 November 2023 12:12 PM UTC+00 Business Wire India Rusan Pharma, a leading pharmaceutical company committed to improving healthcare globally and pioneering pain management and addiction solutions worldwide – recently achieved a momentous milestone with the launch of its state-of-the-art API facility in Pithampur, Special Economic Zone (SEZ), Madhya Pradesh. This achievement represents Rusan Pharma's unwavering commitment to addressing the alarming rise in pain management, drug, alcohol, and tobacco addiction while contributing to the growth of the Indian pharmaceutical industry.   With an approach to sustainable development and technological advancements, the total investment over two phases will be up to INR 300 crores, highlighting Rusan Pharma's commitment to the pharmaceutical sector and its potential impact on the industry's growth and development. The facility is designed to meet stringent international regulatory guidelines, ensuring the highest level of compliance. With the production capability of 400 metric tonnes of APIs annually, the facility significantly contributes to Rusan Pharma's growth and expansion plans, diversifying its portfolio and expanding its reach in India and other markets.   Dr. Navin Saxena, Founder and Chairman – Rusan Pharma, said, "The new API facility in Pithampur, will enable Rusan to significantly enhance our existing API capacity and ensure the security of supply of critical APIs to meet the growing demand for our addiction treatment and pain management products in India and globally. Rusan has invested the last 30 years and pioneered in making the treatment of addiction acceptable and accessible. We firmly believe that access to quality healthcare is a right and not a privilege. Our goal is to ensure that everyone who seeks treatment for addiction and pain management can access it." Strategically situated within the Pithampur Special Economic Zone (SEZ), the new facility will capitalise on the support and subsidies provided by the Madhya Pradesh state government. This central location will streamline business operations and export processes through the dry port, making it an optimal choice for Rusan Pharma's expansion plans. The facility's location in a dedicated pharmaceutical zone ensures a cleaner environment, reducing the risk of pollution from other industries in the area.   Highlighting more about the initiative, Dr. Kunal Saxena – Managing Director, Rusan Pharma said, "At Rusan, we exemplify the 'Make in India' initiative, especially in the area of controlled substances. With an investment of about Rs. 300 crore in two phases, this new API facility will increase our current API manufacturing capacity from 40 metric tonnes in Ankleshwar to 400 metric tonnes in Pithampur. Our new plant boasts five modular API manufacturing blocks with dedicated suites for finished API manufacturing. This grants us complete control over the quality of our products and reduces our dependency on imports, aligning perfectly with our commitment to excellence. Incorporating advanced automation and compliant software will help us move towards paperless manufacturing, along with stringent environmental controls, which will enable us to produce essential medicines more affordably, expanding accessibility to a broader population." The facility in Pithampur sets itself apart with world-class automation, in-house design optimisation and a commitment to environmental controls, resulting in higher yields, reduced production costs, and top-notch product quality. Visually, the facility is an architectural marvel designed to withstand earthquakes and minimise disruption to the natural terrain. The facility's unique feature includes an altitude difference between the ground floors of about 9 meters (3 floors), facilitating the flow of materials and supplies. Its eco-friendly and sustainable design minimises environmental impact while optimising the utilisation of natural resources. The architectural excellence of the facility also showcases robust elements ensuring operational efficiency and resilience. During the construction phase of the Pithampur facility, over 3000 contract workers were employed, and once it is fully operational, the facility will directly generate more than 300 employment opportunities, and over the years, more than 500+ indirect employment opportunities will be created.   Over the years and prior to this, Rusan Pharma has continuously diversified its portfolio. Besides manufacturing, the company has invested heavily in R&D to develop first-time, technologically advanced products. Rusan was the first company to introduce 'Buprenorphine Sublingual and Buprenorphine Naloxone Sublingual Tablets' for the treatment of drug abuse in India. Previously, the company had launched Apomorphine Injections for treating Parkinson's. It also specialises in the category of transdermal patches and was the first company to launch indigenous formulations of Fentanyl, Buprenorphine, and Lidocaine transdermal patches for moderate to chronic pain and Nicotine transdermal patches for tobacco cessation. Rusan's current GMP approvals for its APIs and finished formulations facilities have the potential to cater to 90% of the world's demand. Some of the GMP approvals they are accredited with are Health Canada, TGA-Australia, SAPHRA-South Africa, EU, UAE, and Russia, to name a few. Drug addiction, a global concern, has seen a significant impact with 296 million reported drug users worldwide in 2021, according to the UNODC World Drug Report 20231. In India, the issue persists with 23 million reported drug users in 2019, as reported by the Ministry of Social Justice and Empowerment (MOSJE) in the 'Magnitude of Substance Abuse in India, 20192.   Shifting the focus to alcohol addiction, it is a pervasive global issue, with 2.35 billion3 people (43% of the global population) identified as current consumers of alcohol. The harmful use of alcohol led to 3 million deaths worldwide in 2016, as reported by the WHO Global Status Report on Alcohol and Health in 20184. While in India, 160 million people were identified in alcohol consumption, and a concerning 57 million Indians were reported to need assistance for alcohol use problems, according to MOSJE5.   Tobacco addiction, another critical health challenge, affects 1.3 billion individuals globally. The devastating consequences include more than 8 million deaths annually, with 1.3 million non-smokers succumbing to the effects of second-hand smoke, as reported by the World Health Organization (WHO)6. In India, a staggering 266.8 million adults were identified as current tobacco users in the Global Adult Tobacco Survey Report for India (2016-17)7.   [1] https://www.unodc.org/res/WDR-2023/WDR23_Exsum_fin_SP.pdf [2] https://www.lgbrimh.gov.in/resources/Addiction_Medicine/elibrary/magnitude_substance_abuse_india.pdf [3] https://iris.who.int/bitstream/handle/10665/274603/9789241565639-eng.pdf?sequence=1 [4] https://iris.who.int/bitstream/handle/10665/274603/9789241565639-eng.pdf?sequence=1 [5] https://www.lgbrimh.gov.in/resources/Addiction_Medicine/elibrary/magnitude_substance_abuse_india.pdf [6] https://www.who.int/news-room/fact-sheets/detail/tobacco#:~:text=Around%2080%25%20of%20the%20world's,(WHO%20FCTC)%20in%202003 [7] https://assets.tobaccofreekids.org/global/pdfs/en/GATS_India_2016-17_FactSheet.pdf

Merck Foundation Marks International Day of Elimination of Violence Against Women Saturday 25 November 2023 03:10 PM UTC+00 Business Wire India Merck Foundation, the philanthropic arm of Merck KGaA Germany, together with African First Ladies and local partners, mark the "International Day of Elimination of Violence against Women and Girls 2023" as a part of the Merck Foundation "More Than a Mother" and "Educating Linda" program, through their various community awareness programs to Stop Gender Based Violence, Empower Women & Girls at all levels, Support Girl Education and more.   Senator Dr. Rasha Kelej, CEO of Merck Foundation explained, "At Merck Foundation, we have been continuously working towards raising awareness about elimination of violence against women and girls through many of our initiatives like children's storybooks, songs and also through many episodes of our TV program "Our Africa", broadcasted on National TV Stations across Africa. We started our efforts to eliminate GBV in partnership with Botswana First Lady, via poster contest which was very successful.   Moreover, I strongly believe that Education is one of the most critical areas of women empowerment and can definitely help in eliminating violence of all types against women, therefore, we started our "Educating Linda" program to provide high performance by underprivileged girls with scholarships to continue their school education."   Merck Foundation's pan African TV program "Our Africa", that is conceptualized, produced, directed, and co-hosted by Senator, Dr. Rasha Kelej, CEO of Merck Foundation and features African Fashion Designers, Singers, and prominent experts from various domains with the aim to raise awareness about social and health issues, has episodes dedicated to issues like Stopping GBV, Ending FGM, Women Empowerment and Supporting Girl Education. Watch the Episode about Stopping GBV here: https://www.youtube.com/watch?v=YH3DKwHuvsM   Watch the Episode about Ending FGM here: https://www.youtube.com/watch?v=7GtXkBYv_94   Watch the Episode about Women Empowerment here: https://www.youtube.com/watch?v=xghKVbJi2ds   Watch the Episodes on Girl Education here: https://www.youtube.com/watch?v=jGz6yNSik7g https://www.youtube.com/watch?v=g5wpzOr22l0 https://www.youtube.com/watch?v=QjwRnP-Zi60   Merck Foundation in partnership with The First Ladies of Africa, has launched an inspiring children's storybook – 'Not Who You Are' to raise awareness on Gender Based Violence, to educate children about this sensitive social issue so that they can learn to respect girls and women, from a young age. Moreover, children storybook like 'Educating Linda', 'Jackline's Rescue' and 'Ride into the Future' have also been launched to support girl education.   Merck Foundation is also going to soon launch Animation Films adapted from these storybooks in four different languages.   Read 'Not Who You Are' storybook here: https://merck-foundation.com/merckfoundation/public/uploads/digital_library/1639992445_87746fd4b1fd877162a7.pdf   Read 'Educating Linda' storybook here: https://merck-foundation.com/merckfoundation/public/uploads/digital_library/1623068469_6affa28d861b48da41cf.pdf   Read 'Jackline's Rescue' storybook here: https://merck-foundation.com/merckfoundation/public/uploads/digital_library/1639990408_efbd2346fb16c605c12d.pdf   Read 'Ride into the Future' storybook here: https://merck-foundation.com/merckfoundation/public/uploads/digital_library/1639993429_cca7a831eeb6dbe2c188.pdf   Merck Foundation has also released many songs to support women empowerment and girl education.   Watch, share & subscribe the "Like Them" song here, sung by Kenneth, a famous singer from Uganda: https://www.youtube.com/watch?v=jCo52vtz3Q0 Watch and share "Girl Can" song here, sung by two famous singers, Irene and Cwezi from Liberia and Ghana respectively: https://youtu.be/6LP92vAWYgs Watch and share "Take me to School" song here, sung by Wezi, Afro-soul singer from Zambia, to support girls' education: https://www.youtube.com/watch?v=rWcujLMbKSg Watch and share "Tu Podes Sim" Portuguese song, which means "Yes, You Can" in English by Blaze and Tamyris Moiane, singers from Mozambique in English here: https://youtu.be/BGWR2S-mxl4  Watch and share "ABC, 123" by Sean K from Namibia song here: https://youtu.be/4Z2i4Wh-bpk Watch and share "Superwoman Song" by singers Cwezi and Adina from Ghana here: https://www.youtube.com/watch?v=NQ6ZprqAAJs "Violence against girls, women, and children remains one of the most widespread and devastating violations of human rights not only in Africa but across the world today. Such kind of violence against women remains largely unreported due to lack of education, stigma, and shame. This International Day for the Elimination of Violence against Women, let's unite against gender-based violence. Empower, support, and advocate for girl education and women's rights. Together, we can create a world free from abuse and discrimination," added Senator Dr. Rasha Kelej.   Click on the link below to Download Merck Foundation App https://www.merck-foundation.com/MF_StoreRedirection Join the conversation on our social media platforms below and let your voice be heard!   Facebook: Merck Foundation Twitter: @MerckFoundation YouTube: MerckFoundation Instagram: Merck Foundation Flickr: Merck Foundation www.merck-foundation.com

You received this email because you set up a subscription at Feedrabbit. This email was sent to you at epaperindia10@gmail.com. Unsubscribe or change your subscription.